Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Tacrolimus Given As an Alternative to Cyclosporin after Allogeneic HSCT in Case of Renal Impairment: A Prospective Pilot Study

Marie Y Detrait, MD, Stéphane Morisset, Stat, Anne Beatrice Notarantonio, Pochon Cecile, Sabine Cohen, Catherine Rioufol, PharmD, Gabrielle Roth Guepin, Maud D'Aveni, Adele Dhuyser, Sylvie Tarillon, Chapel Valerie, Marie t Rubio, MDPhD, Barraco Fiorenza, Mauricette Michallet, MD PhD

Blood (2016) 128 (22): 5749.

https://doi.org/10.1182/blood.V128.22.5749.5749

Published: 2016

Journal Articles

Efficacy and Safety of Unrelated Cord Blood Transplantation in Patients with Acquired Refractory Aplastic Anemia: A Phase II Study on Behalf of Eurocord and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

Blood (2016) 128 (22): 2671.

https://doi.org/10.1182/blood.V128.22.2671.2671

Published: 2016

Journal Articles

A Composite Event-Free Survival End Point to Evaluate Outcome after Allogeneic Transplantation for Severe Aplastic Anemia: A Study on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Raynier Devillier, MD PhD, Hélène Labussière-Wallet, MD, Laurence Clément, MD, Ibrahim Yakoubagha, Jacques-Olivier Bay, MD PhD, Virginie Gandemer, MD PhD, Marie t Rubio, MD PhD, Anne Sirvent, MD, Patrice Chevallier, MD PhD, Thierry Derevel, Sebastien Maury, MD PhD, Gerard Socie, MD PhD, Regis Peffault de Latour, MD PhD

Blood (2016) 128 (22): 2674.

https://doi.org/10.1182/blood.V128.22.2674.2674

Published: 2016

Journal Articles

Romiplostim in Patients Undergoing Allogeneic Stem Cell Transplantation: Results of a Phase I/II Multicenter Trial

Régis Peffault de Latour, MD, Sylvie Chevret, MD PhD, Annalisa Ruggeri, MD, Felipe Suarez, MD PhD, Laetitia Souchet, MD, David Michonneau, MD PhD, Flore Sicre de Fontbrune, Tereza Coman, MD PhD, Marie t Rubio, MDPhD, Stéphanie Nguyen, MD PhD, Mohamad Mohty, MD PhD, Gerard Socie, MD PhD

Blood (2016) 128 (22): 65.

https://doi.org/10.1182/blood.V128.22.65.65

Published: 2016

Journal Articles

Association Between Multiple Mismatches at the HLA-DPB1 and DRB3/4/5 Genes and Adverse Outcomes in HLA-a, -B, -C, -DRB1 and -DQB1 Identical Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC) and the Francophone Society for Histocompatibility and Immunogenetics (SFHI)

Blood (2016) 128 (22): 4660.

https://doi.org/10.1182/blood.V128.22.4660.4660

Published: 2016

Journal Articles

Bortezomib As Salvage Treatment for Multiple Myeloma Relapsing after Allogeneic Haematopoietic Stem Cell Transplantation: Efficacy, Tolerance and Modulation of Graft Versus Host Disease: A Study of the French Society for Stem Cell Transplantation and Cell Therapies (SFGM-TC)

Blood (2014) 124 (21): 3959.

https://doi.org/10.1182/blood.V124.21.3959.3959

Published: 2014

Journal Articles

Phenotypic and Functional Characterization Of a Novel Immature Hematopoietic Myeloid Suppressive Progenitor Cells Mobilized By G-CSF. Application To Gvhd Treatment

Marie T Rubio, MD, PhD, Maud D'Aveni, MD, Tereza Coman, MD, Julien Rossignol, Julie Bruneau, MD, Flora Zavala, PhD, Anne C. Brignier, MD, Felipe Suarez, MD, PhD, Mohamad Mohty, MD, PhD, Olivier Hermine, MD, PhD

Blood (2013) 122 (21): 4476.

https://doi.org/10.1182/blood.V122.21.4476.4476

Published: 2013

Journal Articles

Ruxolitinib For Patients With Primary Or Secondary Myelofibrosis before Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT): A Retrospective Study Of The Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Delphine Lebon, Marie T Rubio, MD, PhD, Faezeh Legrand, MD, PhD, Jean-Jacques Kiladjian, MD, PhD, Mohamad Mohty, MD, PhD, Jean-Yves Cahn, MD, Laure Vincent, MD, Amandine Charbonnier, MD, Nicole Raus, Gérard Socié, MD, PhD, Marie Robin, MD, PhD

Blood (2013) 122 (21): 2111.

https://doi.org/10.1182/blood.V122.21.2111.2111

Published: 2013

Journal Articles

Association of Deferasirox and Vitamin D Promotes Cell Differentiation and Improves Overall Survival in Acute Myeloid Leukemia (AML) Elderly Patients After Demethylating Agents Failure: A Retrospective Case Control Study

Etienne Paubelle, Felipe Suarez, MD, PhD, Florence Zylbersztejn, Celine Callens, PharmD PhD, Michael Dussiot, Marc Benhamou, Françoise Isnard, MD, Marie T Rubio, MD, PhD, Gandhi Damaj, Norbert C. Gorin, MD, PhD, Jean-Pierre Marolleau, MD, PhD, Ivan Cruz Moura, PhD, Olivier Hermine

Blood (2012) 120 (21): 3622.

https://doi.org/10.1182/blood.V120.21.3622.3622

Published: 2012

Journal Articles

Treatment of Relapse After Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndrome: A Large-Scale Study On Behalf of the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Blood (2012) 120 (21): 593.

https://doi.org/10.1182/blood.V120.21.593.593

Published: 2012

Journal Articles

Impact of Azacitidine (AZA) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) for Myelodysplastic Syndromes (MDS): A Large-Scale Study on Behalf of the SFGM-TC and GFM Groups

Gandhi Damaj, MD, Julia Salleron, Marie Robin, Mauricette Michallet, Mohamad Mohty, Vigouroux Stephane, Yves Beguin, MD, PhD, Alice Garnier, Bruno Lioure, Jean El Cheikh, MD, PhD, Nathalie Fegueux, Jérôme Cornillon, Lionel Ades, Sylvie Francois, MD, Marie T Rubio, MD, PhD, Sophie Park, Federico Garnier, MD, Pierre Fenaux, MD, PhD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2011) 118 (21): 160.

https://doi.org/10.1182/blood.V118.21.160.160

Published: 2011

Journal Articles

Hematopoietic Multipotent Progenitor Cells Mobilized by G-CSF Can Inhibit Gvhd

Maud D'Aveni, MD, Julien Rossignol, Ruddy Montandon, Marie Bouillie, Flora Zavala, PhD, O. Hermine, MD, PhD, Marie T Rubio, MD, PhD

Blood (2011) 118 (21): 2969.

https://doi.org/10.1182/blood.V118.21.2969.2969

Published: 2011

Journal Articles

Interest of the Association Azacitidine-Lenalidomide As Front Line Therapy in High-Risk Myelodysplasia (MDS) or Acute Myeloid Leukemia (AML) with Complex Karyotype

Elodie Scherman, Sandra Malak, MD, Christine Perot, MD, Norbert C. Gorin, MD, PhD, Marie T Rubio, MD, PhD, Françoise Isnard, MD

Blood (2011) 118 (21): 5035.

https://doi.org/10.1182/blood.V118.21.5035.5035

Published: 2011

Journal Articles

Is There Still a Place for Total Body Irradiation (TBI) In the Conditioning Regimen of Autologous Stem Cell Transplantation In Mantle Cell Lymphoma ?: a Retrospective Study From the Lymphoma Working Party of the EBMT

Blood (2010) 116 (21): 688.

https://doi.org/10.1182/blood.V116.21.688.688

Published: 2010

Journal Articles

Response to Adjuvanted Monovalent Influenza A (H1N1)v Vaccine In Allogeneic Hematopoietic Stem Cell Transplant Recipients

Nathalie Dhedin, MD, Jacques-Olivier Bay, MD, PhD, Patricia Ribaud, Mathieu Coudert, Marie T Rubio, MD, PhD, Philippe Agape, MD, Anne Thiebaut, MD, Alice Garnier, MD, Aurelie Faugeras, Nicole Lecorre, Madalina Uzunov, Nabila Kerbi-Hamimed, Gérard Socié, Noel Milpied, MD, Brigitte Autran, Anne Krivine, MD, PHD

Blood (2010) 116 (21): 1269.

https://doi.org/10.1182/blood.V116.21.1269.1269

Published: 2010

Journal Articles

Impact of Donor-Derived Invariant Natural Killer T (iNKT) Cell Reconstitution After Allogeneic Haematopoietic Stem Cell Transplantation.

Marie T Rubio, Lucia Teixeira, Pierre Milpied, Emmanuel Bachy, Felipe Suarez, David Ghez, Richard Delarue, Agnès Buzyn, Sophie Caillat-Zucman, Bruno Varet, Olivier Hermine, Maria Leite de Moraes

Blood (2009) 114 (22): 346.

https://doi.org/10.1182/blood.V114.22.346.346

Published: 2009

Journal Articles

Prognostic Significance of Complement System Activation After Allogeneic Hematopoietic Stem Cell Transplantation.

Marie T Rubio, Marie A Durey-Dragon, Yi Wang, Jacques Blouin, Sebastien Jacquelin, Pierre Milpied, Felipe Suarez, Richard Delarue, Agnès Buzyn, Bruno Varet, Wolf H Fridman, Véronique Fremeaux-Bacchi, Olivier Hermine

Blood (2009) 114 (22): 1166.

https://doi.org/10.1182/blood.V114.22.1166.1166

Published: 2009

Journal Articles

Complement System Activation after Allogeneic Bone Marrow Transplantation May Early Predict the Development of Acute Gastrointestinal GVHD.

Marie T. Rubio, MD, PhD, Marie A. Dragon-Durey, MD, PhD, Sébastien Jacquelin, Jacques Blouin, Natacha Maillard, MD, David Ghez, MD, Felipe Suarez, MD, Richard Delarue, MD, Agnès Buzyn, MD, PhD, Bruno Varet, MD, Wolf H. Fridman, MD, PhD, Véronique Frémeaux-Bacchi, MD, PhD, Olivier Hermine, MD, PhD

Blood (2007) 110 (11): 2186.

https://doi.org/10.1182/blood.V110.11.2186.2186

Published: 2007

Journal Articles

Prediction of Relapse Risk by Day 100 BCR-ABL Quantification after Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukaemia.

Marie T. Rubio, MD, PhD, Vahid Asnafi, MD, Eric Delabesse, MD, PhD, Gandhi Damaj, MD, Nathalie Dhedin, MD, Bruno R. Varet, MD, Agnes Buzyn, MD, PhD, Elizabeth A. Macintyre, MD, PhD

Blood (2005) 106 (11): 2020.

https://doi.org/10.1182/blood.V106.11.2020.2020

Published: 2005

Journal Articles

Clinical Relevance of Recipient Leukocyte Infusion (RLI) Therapy.

Toshiki I. Saito, MD, PhD, Marie T. Rubio, MD, Megan Sykes, MD

Blood (2004) 104 (11): 2120.

https://doi.org/10.1182/blood.V104.11.2120.2120

Published: 2004

NARROW

Tacrolimus Given As an Alternative to Cyclosporin after Allogeneic HSCT in Case of Renal Impairment: A Prospective Pilot Study

Efficacy and Safety of Unrelated Cord Blood Transplantation in Patients with Acquired Refractory Aplastic Anemia: A Phase II Study on Behalf of Eurocord and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

A Composite Event-Free Survival End Point to Evaluate Outcome after Allogeneic Transplantation for Severe Aplastic Anemia: A Study on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Romiplostim in Patients Undergoing Allogeneic Stem Cell Transplantation: Results of a Phase I/II Multicenter Trial

Bortezomib As Salvage Treatment for Multiple Myeloma Relapsing after Allogeneic Haematopoietic Stem Cell Transplantation: Efficacy, Tolerance and Modulation of Graft Versus Host Disease: A Study of the French Society for Stem Cell Transplantation and Cell Therapies (SFGM-TC)

Phenotypic and Functional Characterization Of a Novel Immature Hematopoietic Myeloid Suppressive Progenitor Cells Mobilized By G-CSF. Application To Gvhd Treatment

Ruxolitinib For Patients With Primary Or Secondary Myelofibrosis before Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT): A Retrospective Study Of The Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Association of Deferasirox and Vitamin D Promotes Cell Differentiation and Improves Overall Survival in Acute Myeloid Leukemia (AML) Elderly Patients After Demethylating Agents Failure: A Retrospective Case Control Study

Treatment of Relapse After Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndrome: A Large-Scale Study On Behalf of the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Impact of Azacitidine (AZA) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) for Myelodysplastic Syndromes (MDS): A Large-Scale Study on Behalf of the SFGM-TC and GFM Groups

Hematopoietic Multipotent Progenitor Cells Mobilized by G-CSF Can Inhibit Gvhd

Interest of the Association Azacitidine-Lenalidomide As Front Line Therapy in High-Risk Myelodysplasia (MDS) or Acute Myeloid Leukemia (AML) with Complex Karyotype

Is There Still a Place for Total Body Irradiation (TBI) In the Conditioning Regimen of Autologous Stem Cell Transplantation In Mantle Cell Lymphoma ?: a Retrospective Study From the Lymphoma Working Party of the EBMT

Response to Adjuvanted Monovalent Influenza A (H1N1)v Vaccine In Allogeneic Hematopoietic Stem Cell Transplant Recipients

Impact of Donor-Derived Invariant Natural Killer T (iNKT) Cell Reconstitution After Allogeneic Haematopoietic Stem Cell Transplantation.

Prognostic Significance of Complement System Activation After Allogeneic Hematopoietic Stem Cell Transplantation.

Complement System Activation after Allogeneic Bone Marrow Transplantation May Early Predict the Development of Acute Gastrointestinal GVHD.

Prediction of Relapse Risk by Day 100 BCR-ABL Quantification after Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukaemia.

Clinical Relevance of Recipient Leukocyte Infusion (RLI) Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only